----
Current ValuationThe current P/E ratio is 104.75, above the reasonable range, cheaper than 13.41% of the time in the past 1 years, and the industry ranks 16/22, the industry Median 8.58.
104.75xP/E
HK$2.66Stock price
HK$0.03Earnings per share
104.75xP/E
Stock priceHK$2.66Earnings per shareHK$0.03
Historical Valuation
P/E ratioTypical rangeMedian
- P/E ratio
- -258.26x
- Typical range
- -453.11x–-137.22x
Peer P/E ratio Comparison
It displays how the company's P/E ratio compares to top companies within its industry.
Industry median 8.58x
0275481108
Industry P/E ratio Comparison
This shows the distribution of companies by P/E ratio range and their projected earnings per share growth for the next fiscal year.
Industry median 8.58x
0x20x40x60x80x100x
| Name/Symbol | |||
|---|---|---|---|
02609HKBAYZED HEALTH | 104.75x | -- | HK$3.51B |
Risk Warning
Timeframes using financial data from S&P Global. The feature provides key metrics such as price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S) ratios, and dividend yield. For reference only and does not constitute investment advice.
